Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Krzysztof Warzocha; Wojciech Homenda; Andrzej Pluta; Tomasz Sacha; Maria Cioch; Marek Dudziński; Dorota Krochmalczyk; Joanna Góra-Tybor; Ilona Seferyńska; Monika Joks; Marta Sobas

doi:10.5603/OCP.2019.0021

Oncology in Clinical Practice
Vol 15, No 3 (2019) Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Vol 15, No 3 (2019)

Review paper

Published online: 2019-06-26

View PDF Download PDF file

Page views 889

Article views/downloads 1342

Get Citation

Connect on Social Media

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Krzysztof Warzocha¹, Wojciech Homenda², Andrzej Pluta³, Tomasz Sacha³, Maria Cioch⁴, Marek Dudziński⁵, Dorota Krochmalczyk⁶, Joanna Góra-Tybor¹, Ilona Seferyńska¹, Monika Joks⁷, Marta Sobas⁸

DOI: 10.5603/OCP.2019.0021

Oncol Clin Pract 2019;15(3):167-179.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

Oncology in Clinical Practice

About Via Medica Advertising

Bookstore (Ikamed) TVMed

News